Cargando…
Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
Glioblastoma (GBM), a highly aggressive form of brain tumor, responds poorly to current conventional therapies, including surgery, radiation therapy, and systemic chemotherapy. The reason is that the delicate location of the primary tumor and the existence of the blood-brain barrier limit the effect...
Autores principales: | Qi, Zhongbing, Long, Xiangyu, Liu, Jiyan, Cheng, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507431/ https://www.ncbi.nlm.nih.gov/pubmed/36159398 http://dx.doi.org/10.3389/fncel.2022.819363 |
Ejemplares similares
-
Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
por: Marchica, Valentina, et al.
Publicado: (2021) -
Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
por: Liu, Junfeng, et al.
Publicado: (2023) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response
por: Stavrakaki, Eftychia, et al.
Publicado: (2021) -
Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
por: Webb, Mason J., et al.
Publicado: (2023)